MR spectroscopy (MRS) and magnetisation transfer imaging (MTI), lesion load and clinical scores in early relapsing remitting multiple sclerosis: a combined cross-sectional and longitudinal study

No abstract is available for this paper.

• Publication year

  2009

• Venue

  European Radiology

• Publication date

  2009-03-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00330-009-1364-zPMID 19308417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome

  2008cited by this paper
• MR in the diagnosis and monitoring of multiple sclerosis: an overview.

  2008cited by this paper
• Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions

  2008cited by this paper
• Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis

  2008cited by this paper
• Non-conventional MRI techniques for measuring neuroprotection, repair and plasticity in multiple sclerosis

  2008cited by this paper
• MRI in multiple sclerosis: current status and future prospects.

  2008cited by this paper
• MRI in multiple sclerosis: What’s inside the toolbox?

  2007cited by this paper
• Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?

  2007cited by this paper
• High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis

  2007cited by this paper
• Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis

  2007cited by this paper
• Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease

  2007cited by this paper
• Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion

  2007cited by this paper
• Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis

  2007cited by this paper
• Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study.

  2007cited by this paper
• Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case–control study

  2007cited by this paper
• Multiple sclerosis: new insights and trends.

  2006cited by this paper
• Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.

  2006influential reference
• Magnetization transfer imaging of multiple sclerosis

  2005cited by this paper
• Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis

  2005influential reference
• Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

  2005cited by this paper
• Magnetic Resonance Spectroscopy in the Monitoring of Multiple Sclerosis

  2005cited by this paper
• Neurodegeneration and clinical relevance for early treatment in multiple sclerosis.

  2005cited by this paper
• Magnetization Transfer Imaging in Multiple Sclerosis

  2005cited by this paper
• Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis

  2004influential reference
• Diffusely elevated cerebral choline and creatine in relapsing‐remitting multiple sclerosis

  2003cited by this paper
• Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis

  2003cited by this paper
• Imaging neuronal and axonal degeneration in multiple sclerosis

  2003cited by this paper
• Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis

  2003influential reference
• Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis.

  2003influential reference
• The use of quantitative magnetic-resonance-based techniques to monitor the evolution of multiple sclerosis.

  2003cited by this paper
• The worldwide prevalence of multiple sclerosis.

  2002influential reference
• Proton MR spectroscopic imaging in multiple sclerosis

  2002cited by this paper
• Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy

  2001cited by this paper
• Editorial commentary to Narayanan et al. Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b.

  2001cited by this paper
• Diagnostic criteria for multiple sclerosis.

  2001cited by this paper
• Axonal metabolic recovery in multiple sclerosis patients treated with interferon β–1b

  2001cited by this paper
• Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

  2001cited by this paper
• Magnetisation transfer imaging in multiple sclerosis.

  2000cited by this paper
• Magnetization transfer ratio in new MS lesions before and during therapy with IFNβ-1a

  2000cited by this paper
• Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis.

  2000cited by this paper
• Magnetization transfer ratio in new MS lesions before and during therapy with IFNbeta-1a.

  2000cited by this paper
• Development of a multiple sclerosis functional composite as a clinical trial outcome measure.

  1999cited by this paper
• Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.

  1998cited by this paper
• Serial whole-brain magnetization transfer imaging in patients with relapsing-remitting multiple sclerosis at baseline and during treatment with interferon beta-1b.

  1998cited by this paper
• Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

  1998cited by this paper
• 1H-MRS in patients with multiple sclerosis undergoing treatment with interferon β-1a: results of a preliminary study

  1998cited by this paper
• Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

  1996cited by this paper
• Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies.

  1991cited by this paper

• Repair mechanisms of the central nervous system: From axon sprouting to remyelination

  2025cites this paper
• Evaluation of the Utility of Hybrid PET/MR Neuroimaging in Inflammatory Demyelination and Encephalitis

  2025cites this paper
• Reconciling lesions, relapses and smouldering associated worsening: A unifying model for multiple sclerosis pathogenesis.

  2024cites this paper
• Quantitative magnetization transfer imaging in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis

  2022cites this paper
• Quantitative magnetisation transfer imaging in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.

  2021influential citation
• Magnetic Resonance Spectroscopy

  2021cites this paper
• Quantifying the Metabolic Signature of Multiple Sclerosis by in vivo Proton Magnetic Resonance Spectroscopy: Current Challenges and Future Outlook in the Translation From Proton Signal to Diagnostic Biomarker

  2019cites this paper
• A 24-month advanced magnetic resonance imaging study of multiple sclerosis patients treated with alemtuzumab

  2019cites this paper
• Does MR spectroscopy of normal-appearing cervical spinal cord in patients with multiple sclerosis have diagnostic value in assessing disease progression? A prospective comparative analysis.

  2018cites this paper
• Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis

  2018cites this paper
• A Comparison of N-acetyl Aspartate Concentrations between Two Main Subtypes of Multiple Sclerosis using Magnetic Resonance Spectroscopy Imaging

  2017cites this paper
• The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials

  2017cites this paper
• Magnetic Resonance Spectroscopy

  2017cites this paper
• Monitoring interferon β treatment response with magnetic resonance spectroscopy in relapsing remitting multiple sclerosis

  2016cites this paper
• Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies

  2016cites this paper
• Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management

  2015cites this paper
• Relapsing-Remitting Multiple Sclerosis Natalizumab Treatment in Enhanced Axonal Metabolism during Early

  2015cites this paper
• Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis

  2015cites this paper
• Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing–remitting multiple sclerosis (RRMS)

  2015cites this paper
• Molecular mechanisms linking neuroinflammation and neurodegeneration in MS.

  2014cites this paper
• Pathologic and Imaging Correlates of Cognitive Deficits in Multiple Sclerosis: Changing the Paradigm of Diagnosis and Prognosis

  2014cites this paper
• Magnetic Resonance Spectroscopy (MRS)

  2014cites this paper
• Should quantitative MRI sequences become part of routine imaging for Multiple Sclerosis

  2014cites this paper
• Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter

  2014cites this paper
• 1 H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment

  2013cites this paper
• Hippocampal Magnetization Transfer Ratio at 3T: Validation of Automated Postprocessing and Comparison of Quantification Metrics

  2013cites this paper
• Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS

  2013cites this paper
• 1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment

  2013cites this paper
• Lesion contrast differences in MRI sequences in multiple sclerosis: Correlation to clinical disability

  2013influential citation
• Cognitive Impairment in Neurological Diseases: Lessons from Apolipoprotein E

  2013cites this paper
• Identification of inflammatory neuronal injury and prevention of neuronal damage in multiple sclerosis: hope for novel therapies?

  2013cites this paper
• 1 HMR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment

  2013cites this paper
• Comprehensive brain analysis with automated high‐resolution magnetization transfer measurements

  2012cites this paper
• A magnetization transfer imaging study of corpus callosum myelination in young children with autism.

  2012cites this paper
• Clinical use of H1 MR spectroscopy in assessment of relapsing remitting and secondary progressive multiple sclerosis

  2012cites this paper
• MAGNETIC RESONANCE SPECTROSCOPY (MRS) FOR EVALUATION OF NEUROLOGICAL DISORDERS

  2012cites this paper
• Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis

  2012cites this paper
• Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study

  2012cites this paper
• Functional MRI of Multiple Sclerosis

  2011cites this paper
• Neuroimaging of Cardiovascular Disease

  2011cites this paper
• Analysis of multiple sclerosis lesions using a fusion of 3.0 T FLAIR and 7.0 T SWI phase: FLAIR SWI

  2011cites this paper
• Current Awareness in NMR in Biomedicine

  2010cites this paper
• Composite MRI scores improve correlation with EDSS in multiple sclerosis

  2010cites this paper
• Reduced NAA-Levels in the NAWM of Patients with MS Is a Feature of Progression. A Study with Quantitative Magnetic Resonance Spectroscopy at 3 Tesla

  2010cites this paper
• Magnetic Resonance Spectroscopy (mrs) Magnetic Resonance Spectroscopy (mrs) Medicare & Medicaid Coverage Rationale Medicare Has a National Coverage Determination for Magnetic Resonance Spectroscopy (220.2.1) Indications and Limitations of Coverage Nationally Non-covered Indications

  year unknowncites this paper